Insider Transactions in Q4 2024 at Leap Therapeutics, Inc. (LPTX)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 13
2024
|
Douglas E Onsi CEO,CFO,Pres.,GC,Treas.&Sec. |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
2,136
+0.31%
|
$4,272
$2.82 P/Share
|
|
Nov 13
2024
|
James H Cavanaugh Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
213
+50.0%
|
$426
$2.82 P/Share
|
|
Nov 13
2024
|
Christopher Mirabelli Chairman of the Board |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
2,136
+0.31%
|
$4,272
$2.82 P/Share
|
|
Nov 13
2024
|
Augustine Lawlor Chief Operating Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
2,136
+0.31%
|
$4,272
$2.82 P/Share
|